Boyds
The consultancy – which in February month also opened a new office in Dublin, Ireland ahead of Brexit – has made several hires.
Boyds also has established a clinical and medical affairs group to provide pharmaceutical medicine and medical monitoring support. Dr. Lalitha Mahadavan will lead the group backed by her experience in leading global projects and regulatory submissions for biopharmaceutical companies including Johnson & Johnson, Biogen, and the NHS.
Mahadavan is a consultant in pharmaceutical medicine (GMC registered) and a fellow of the Faculty of Pharmaceutical Medicine, as well as a member of its Board of Trustees and a Faculty Revalidation Appraiser.
Professor Alan Boyd, Founder and CEO of Boyds, said: “I am delighted to be formally establishing the Clinical and Medical Affairs Group at Boyds, which forms part of our 2019 growth vision, and welcoming Dr. Mahadavan to lead the team.
